Calvert Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-17,845
Closed -$716K 259
2016
Q4
$716K Sell
17,845
-426
-2% -$16.4K 0.03% 463
2016
Q3
$709K Buy
18,271
+3,027
+20% +$114K 0.03% 464
2016
Q2
$527K Buy
15,244
+122
+0.8% +$4.22K 0.02% 489
2016
Q1
$522K Buy
15,122
+3,627
+32% +$126K 0.02% 470
2015
Q4
$445K Buy
11,495
+2,684
+30% +$104K 0.02% 477
2015
Q3
$345K Buy
8,811
+340
+4% +$13.5K 0.02% 432
2015
Q2
$322K Sell
8,471
-2,080
-20% -$72.8K 0.01% 483
2015
Q1
$348K Buy
10,551
+1,599
+18% +$49.1K 0.02% 458
2014
Q4
$239K Buy
8,952
+101
+1% +$2.61K 0.02% 518
2014
Q3
$215K Buy
+8,851
New +$224K 0.02% 532

Other funds holding HOLX

Calvert Investment Management's HOLX Position: Q1 2017 in Review

Calvert Investment Management sold out of Hologic (HOLX) in Q1 2017, closing a stake of 17,845 shares — an estimated $716K sold.

Calvert Investment Management first reported a position in HOLX in Q3 2014 and held it in 10 quarters. The position peaked at $716K in Q4 2016. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

  • Calvert Investment Management reported no remaining Hologic position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 17,845 Hologic shares in Q1 2017, an estimated $716K.
  • Calvert Investment Management first reported a position in Hologic in Q3 2014 and held it in 10 quarters.
  • Calvert Investment Management's Hologic position peaked at $716K in Q4 2016.
  • 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.